Address
Abingworth Bioventures II LP
38 Jermyn Street
London
SW1Y 6DN
United Kingdom
Website
VCID: 24407
Profile
Corporate information
Official name
Abingworth Bioventures II LP
Registration country
Official name
Abingworth Bioventures II LP
Registration country
Investment activity status
Not investing
Company type
Venture capital fundFund terms
Funding
Funding rounds
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Quantum Dot Corp |
United States | 31 Dec 2011 | N/A Active |
|
|
|
Protein Mechanics |
United States | 31 Dec 2001 | N/A Active |
|
|
|
Entelos Inc |
United States | 31 Dec 2000 | N/A Active |
|
|
|
Epigenomics |
Germany | 31 Dec 2000 | N/A Active |
|
|
|
Micromet Inc Designs and develops innovative antibody based drugs for the treatment of cancer, autoimmune and inflammatory diseases |
United States | 31 Dec 2000 | N/A Active |
|
|
|
Oxagen Ltd |
United Kingdom | 31 Dec 2000 | N/A Active |
|
|
|
Clinical Designs |
United Kingdom | 31 Dec 2000 | N/A Active |
|
|
|
Adiana Inc |
United States | 31 Dec 1999 | N/A Active |
|
|
|
ArgoMed |
United States | 31 Dec 1999 | N/A Active |
|
|
|
Astex Pharmaceuticals Inc Drug discovery, development and commercialization. |
United States | 31 Dec 1999 | N/A Active |
|
|
Sensors for Medicine and Science |
United States | 31 Dec 1998 | N/A Active |
|
|
|
Solexa Ltd |
United Kingdom | 31 Dec 1998 | N/A Active |
|
|
|
Sunesis Pharmaceuticals Inc Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he |
United States | 31 Dec 1998 | N/A Active |
|
|
|
Lorantis |
United States | 31 Dec 1998 | N/A Active |
|
|
|
WebMD Corp |
United States | 31 Dec 1997 | N/A Active |
|
|
|
Devgen NV |
Belgium | 31 Dec 1997 | N/A Active |